In 2019, while many companies hesitated due to ageing facilities and branding challenges, we focused on what truly matters: the product, technology, knowledge, and expertise. This dedication led to the establishment of Chirorab, enabling a successful transition from Rabipur and securing a strong presence in a competitive market with approximately 35-40% market share.

Based in Gujarat, India, we pride ourselves on maintaining cutting-edge manufacturing capabilities and high-technology jobs. Our production capacity has nearly doubled from 8 million doses per year (MDS) to 15 million MDS, positioning us as one of India’s largest rabies vaccine manufacturers.

Today, with ongoing export registrations in around 40 countries and a partnership with Bharat Biotech, Chiron Behring is one of the largest rabies vaccine manufacturers worldwide, committed to advancing public health through innovation and excellence